Get started
Author

Yulia A. Desheva

Observed names: Desheva Yu. A., Iu A Desheva, J.A Desheva, J.A. Desheva, Julia A Desheva, Julia A. Desheva, Julia Desheva, Y Desheva, Y. A. Desheva, Y.A. Desheva, Yu A Desheva, Yu. A. Desheva, Yu. Desheva, Yu.A. Desheva, Yulia A Desheva, Yulia Desheva, Yuliya A. Desheva, Ю. А. Дешева
ORCID: 0000-0001-9794-3520
Observed ORCID: 0000-0001-9794-3520
OpenAlex ID: A5075227497
6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry
2008 · Alexandra S Gambaryan, Alexander B Tuzikov, et al. · Virology Journal · 119
PDF
Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses
2006 · Xiuhua Lu, Lindsay E. Edwards, et al. · Vaccine · 106
Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents
2000 · Larisa G Rudenko, Nancy H Arden, et al. · Vaccine · 78
Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine
2014 · Larisa Rudenko, Irina Kiseleva, et al. · PLoS ONE · 58
PDF
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)
2008 · Larisa Rudenko, Julia Desheva, et al. · Influenza and Other Respiratory Viruses · 57
PDF
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential
2006 · J.A. Desheva, X.H. Lu, et al. · Vaccine · 56
Anti–Influenza Activity of Enterocin B In vitro and Protective Effect of Bacteriocinogenic Enterococcal Probiotic Strain on Influenza Infection in Mouse Model
2018 · E. I. Ermolenko, Y. A. Desheva, et al. · Probiotics and Antimicrobial Proteins · 51
Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
2020 · Yulia Desheva, Tatiana Smolonogina, et al. · Antibodies · 15
PDF
[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
2002 · E P Grigor'eva, Iu A Desheva, et al. · PubMed · 15
Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus
2022 · Alexander Suvorov, Tatiana Gupalova, et al. · Frontiers in Pharmacology · 14
Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals
2018 · Yulia Desheva, Ivan Sychev, et al. · PLoS ONE · 14
PDF
Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase
2021 · Yulia Desheva, Galina Leontieva, et al. · Microorganisms · 11
PDF
Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
2023 · Mariia V. Sergeeva, E Romanovskaya-Romanko, et al. · Vaccines · 10
PDF
Mast cell degranulation and histamine release during A/H5N1 influenza infection in influenza-sensitized mice
2020 · Yulia Desheva, Andrey Mamontov, et al. · Life Sciences · 9
PDF
The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures
2020 · I.R. Gazizova, Yu.A. Desheva, et al. · Russian Journal of Clinical Ophthalmology · 9
Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models
2014 · Andrey Rekstin, Yulia Desheva, et al. · The Open Microbiology Journal · 9
PDF
Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice
2019 · T. Kramskaya, G. Leontieva, et al. · PLoS ONE · 8
PDF
Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides
2017 · Yulia A Desheva, Galina F Leontieva, et al. · Virology Research and Treatment · 8
PDF
[The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children].
2002 · Iu A Desheva, G V Danini, et al. · PubMed · 8
Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection
2019 · Yulia A. Desheva, Galina F. Leontieva, et al. · Heliyon · 7
PDF
Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides
2016 · Yulia A. Desheva, Galina F. Leontieva, et al. · The Open Microbiology Journal · 7
PDF
Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
2015 · Yulia A Desheva, Tatiana A Smolonogina, et al. · BMC Research Notes · 7
PDF
The Persistence of Cross-Reactive Immunity to Influenza B/Yamagata Neuraminidase Despite the Disappearance of the Lineage: Structural and Serological Evidence
2025 · Yulia Desheva, Polina Kudar, et al. · International Journal of Molecular Sciences · 6
PDF
Comparative Efficacy of Parenteral and Mucosal Recombinant Probiotic Vaccines Against SARS-CoV-2 and S. pneumoniae Infections in Animal Models
2024 · Galina Leontieva, Tatiana Kramskaya, et al. · Vaccines · 6
Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections
2019 · Yulia Desheva, Galina Leontieva, et al. · PLoS ONE · 6
PDF
Works count: 98
Citation count: 794
H-index: 11
I10-index: 13
Year
Topic
Type